Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R > Treatment > Co: USA. C. Brand Lenalidomide Cap> > Patent>Assignee; Claims; No.; Etc.

---

01 05,635,517. Celgene Corp.
02 07,465,800. Celgene Corp.
03 07,468,363. Celgene Corp.
04 07,855,217. Celgene Corp.
05 07,863,451. Celgene Corp.
06 07,893,045. Celgene Corp.
07 07,977,357. Celgene Corp.
08 08,058,443. Celgene Corp.
09 08,143,286. Celgene Corp.
10 08,193,219. Celgene Corp.
11 08,431,598. Celgene Corp.
12 08,741,929. Celgene Corp.
13 08,822,499. Celgene Corp.
14 09,353,080. Celgene Corp.
15 09,365,538. Celgene Corp.
16 09,365,640. Celgene Corp.
17 09,371,309. Celgene Corp.
18 09,808,450. Celgene Corp.
19 09,857,359. Celgene Corp.


Patent>Assignee; Claims; No.; Etc.'s products
This section has no products